ArticleCureus2026
Impact of Antihypertensive, Antihyperlipidemic, and Mixed Antidepressant Medications on Dental Implant Success: A Retrospective Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to analyze the influence of antihypertensive, antihyperlipidemic, and mixed antidepressant medications on the failure and survival rates of dental implants.
methodsOut of a total of 2,815 patients who received 5,853 dental implants between 2012 and 2022, 655 patients with 2,004 implants met the inclusion criteria and were retrospectively reviewed. Patients were divided into four groups: control group (n = 512 patients with 1,581 implants), antihypertensive group (n₁ = 74 patients with 233 implants), antihyperlipidemic group (n₂ = 40 patients with 99 implants), and mixed antidepressant group (n₃ = 29 patients with 91 implants). Implant failure was defined according to the recommendations of the Pisa Consensus Conference of the International Congress of Oral Implantologists.
resultsKaplan-Meier analysis over a 10-year follow-up period showed significant differences in implant survival between the control group and all monotherapy groups. Implant survival was higher in patients receiving antihypertensive or antihyperlipidemic therapy and lower in those treated with mixed antidepressants. Log-rank tests confirmed statistically significant differences compared with controls (
conclusionMixed antidepressant medications are associated with an increased risk of dental implant failure, while antihypertensive and antihyperlipidemic agents appear to have a protective effect, contributing to improved implant survival.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.